Active Ingredient: BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
Proprietary Name: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
Dosage Form; Route of Administration: FILM; BUCCAL, SUBLINGUAL
Strength: EQ 12MG BASE;EQ 3MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207607
Product Number: 002
Approval Date: Jun 14, 2018
Applicant Holder Full Name: MYLAN TECHNOLOGIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information